From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma

@article{Arsanious2009FromBT,
  title={From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma},
  author={Androu Arsanious and G A Georg Bjarnason and George Makram Yousef},
  journal={Molecular Cancer},
  year={2009},
  volume={8},
  pages={20 - 20}
}
Among the adult population, renal cell carcinoma (RCC) constitutes the most prevalent form of kidney neoplasm. Unfortunately, RCC is relatively asymptomatic and there are no tumor markers available for diagnostic, prognostic or predictive purposes. Molecular profiling, the global analysis of gene and protein expression profiles, is an emerging promising tool for new biomarker identification in RCC. In this review, we summarize the existing knowledge on RCC regarding clinical presentation… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 41 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 86 references

Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2005
View 4 Excerpts
Highly Influenced

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2003
View 4 Excerpts
Highly Influenced

CALGA 90206: A phase III trial of bevacizumab plus interferon-alpha versus interferon-alpha monotherapy in metastatic renal cell carcinoma

BI Rini, S Halabi, +3 authors S Ou
ASCO GU conference, A • 2008
View 1 Excerpt

Clinical uses of microarrays in cancer research.

Methods in molecular medicine • 2008
View 1 Excerpt

Similar Papers

Loading similar papers…